DHA vs. EPA: What’s the Difference and Which Do You Need?

Most omega-3 supplements list both DHA and EPA on the label, usually with different milligram amounts, and most buyers treat that information as background noise while focusing on the total omega-3 number. That habit leaves a real question unanswered: since these two fatty acids do different things in the body, does the ratio between them matter? And if so, how should it influence which supplement you choose?

The short answer is yes, the ratio matters, but the degree to which it matters depends on why you are supplementing. For general health maintenance, a product providing meaningful amounts of both is fine. For specific health goals, understanding what each fatty acid actually does puts you in a better position to choose a product whose profile is aligned with your priorities rather than just picking whatever is on sale.

What DHA and EPA Actually Are

DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) are both long-chain polyunsaturated fatty acids in the omega-3 family. They are related but distinct molecules. EPA is a 20-carbon fatty acid with five double bonds; DHA is a 22-carbon fatty acid with six double bonds. The additional carbon atoms and double bond in DHA give it a longer, more flexible structure that allows it to pack into cell membranes with a physical character that influences the membrane’s fluidity and functional properties in ways that shorter fatty acids cannot replicate.

Both are found primarily in marine sources, because the microalgae at the base of marine food chains are the original producers of these fatty acids. Fish accumulate EPA and DHA from eating algae; algae oil supplements provide them directly from the source. ALA, the omega-3 found in plant foods like flaxseed and walnuts, is an 18-carbon precursor that the body can theoretically convert into EPA and DHA, but does so with efficiency so low that it is not a reliable dietary strategy for maintaining adequate EPA and DHA status.

What DHA Does in the Body

DHA is primarily a structural fatty acid. Its most important roles are in the composition of cell membranes in tissues with extraordinary functional demands, specifically the brain, the retina of the eye, and sperm cells. In these tissues, DHA concentrations are extraordinarily high compared to other fatty acids, and the functional properties those tissues depend on are directly linked to DHA’s physical presence in their membrane phospholipids.

DHA in the Brain

Approximately 60 percent of the brain’s dry weight is fat, and DHA is one of the most abundant fatty acids in neuronal cell membranes, particularly in the synaptic regions where neurons communicate. DHA’s multiple double bonds give these membranes a fluidity and flexibility that facilitates the rapid conformational changes required for neurotransmitter receptor function and efficient neural signal transmission. When brain DHA concentrations are adequate, the membranes support the signal transduction speed and receptor sensitivity that underlie cognitive performance. When DHA is insufficient, membrane function is compromised in ways that manifest as reduced cognitive efficiency, slower processing, and impaired memory formation over time.

DHA also plays a role in neurogenesis, the formation of new neurons, and in the structural integrity of myelin, the fatty sheath that insulates nerve fibers and determines the speed of neural signal transmission. These structural roles are why DHA is so critical during fetal brain development, when brain tissue is being built at an extraordinary rate, and why maintaining adequate DHA status is associated with better cognitive aging outcomes in research on older adults.

DHA in the Retina

The retina’s photoreceptor cells, the rods and cones that detect light and translate it into electrical signals, have outer segment membranes with DHA concentrations that exceed even the brain. Estimates suggest DHA makes up more than 50 percent of the fatty acids in photoreceptor outer segment phospholipids. This extraordinary concentration reflects DHA’s role in the physical membrane properties that allow rhodopsin and other visual proteins to undergo the rapid conformational changes required for visual signal transduction. Inadequate retinal DHA impairs this process, with consequences for visual acuity and long-term retinal health.

DHA and Melatonin Synthesis

DHA also plays a less widely known role in melatonin synthesis. Certain DHA-derived prostaglandins are precursors to melatonin production in the pineal gland. Adequate DHA status supports the physiological scaffolding for healthy melatonin production, which connects DHA to the sleep research that has found associations between omega-3 status and sleep quality.

What EPA Does in the Body

EPA’s primary roles are functional and regulatory rather than structural. It is the omega-3 fatty acid most directly involved in the body’s inflammatory signaling system, and this anti-inflammatory function underlies most of the conditions for which EPA shows the strongest and most consistent clinical effects.

EPA and the Eicosanoid Pathway

EPA competes with arachidonic acid (AA), an omega-6 fatty acid, for the enzymes that produce eicosanoids: prostaglandins, thromboxanes, leukotrienes, and related signaling molecules. AA-derived eicosanoids are generally more potent pro-inflammatory mediators than EPA-derived eicosanoids. By increasing the EPA-to-AA ratio in cell membranes through supplementation, omega-3 supplementation gradually shifts the eicosanoid balance toward less inflammatory variants. This is the central mechanism behind EPA’s anti-inflammatory effects on the cardiovascular system, joints, skin, airways, and the central nervous system.

EPA as a Resolvin Precursor

EPA is also the precursor to E-series resolvins, a class of bioactive lipid mediators that actively promote the resolution of inflammation rather than simply suppressing its initiation. This distinction matters because it means EPA is not just reducing inflammation but supporting the body’s ability to conclude inflammatory processes efficiently, which is different from and more sophisticated than what anti-inflammatory medications do. The discovery of resolvins significantly changed scientific understanding of how omega-3 interacts with the immune system, and it explains why omega-3 is associated with faster recovery and better inflammatory resolution rather than just reduced inflammatory intensity.

EPA’s Cardiovascular and Mood Roles

EPA’s anti-inflammatory influence extends to specific systems with well-documented research. In cardiovascular biology, EPA reduces triglycerides, modestly lowers blood pressure, improves endothelial function, and reduces the arterial wall inflammation involved in atherosclerosis progression. In neuroscience and psychiatry, EPA’s anti-inflammatory effects on neuroinflammation, which is increasingly recognized as a driver of depression and anxiety, are the basis for the EPA-dominant findings in mood research. Studies using EPA-dominant formulations consistently show stronger antidepressant effects than those using DHA-dominant formulations, which is one of the clearest DHA-vs-EPA distinctions in the clinical literature.

Where the Research Draws Clear Lines Between Them

Several areas of research have directly compared EPA and DHA effects, producing findings specific enough to guide supplement selection for particular goals.

For depression and mood, EPA is the more relevant fatty acid. Meta-analyses have consistently found that the antidepressant effect of omega-3 supplementation is driven by EPA, and that supplements where EPA comprises at least 60 percent of the omega-3 content show stronger effects than DHA-dominant or balanced products.

For brain structural health, cognitive function, and retinal health, DHA is the primary relevant fatty acid. Research on cognitive aging, visual acuity in infants, and brain volume preservation in older adults consistently implicates DHA’s structural role rather than EPA’s functional one.

For triglyceride reduction, both EPA and DHA contribute, though some research suggests slightly greater potency for DHA specifically on this outcome. For blood pressure reduction, both contribute through overlapping but different mechanisms.

For joint pain and the anti-inflammatory outcomes associated with arthritis management, EPA’s eicosanoid competition mechanism is the primary driver, though DHA-derived resolvins also contribute to the resolution phase.

For athletic recovery, both play roles: EPA through reduced inflammatory peak and DHA through enhanced muscle protein synthetic sensitivity and membrane composition in muscle tissue.

DHA-to-EPA Ratios in Supplements: What You Will Actually Find

Most algae oil supplements are DHA-dominant, reflecting the fatty acid profile of the microalgae species most commonly used in commercial production. Performance Lab Omega-3, for instance, provides a 2:1 DHA-to-EPA ratio (540 mg DHA, 270 mg EPA per serving). Most fish oil supplements targeting general health provide roughly equal EPA and DHA, or slightly EPA-dominant ratios, because the fish species used in their production have different fatty acid profiles from algae.

Prescription EPA-only products like Vascepa (icosapentaenoic acid) provide pure EPA at high doses, specifically for the cardiovascular application where EPA-only formulations have shown the strongest clinical results. These are prescription medications rather than supplements and are used in specific high-risk cardiovascular contexts.

Understanding this landscape helps interpret supplement labels. A DHA-dominant algae oil supplement is not inferior to an EPA-dominant product for most applications. It reflects the natural fatty acid profile of its algae source and is an excellent choice for general health, brain health, eye health, and the structural applications where DHA’s role is primary. For mood support and EPA-specific cardiovascular outcomes, the EPA content deserves specific attention rather than just looking at total omega-3 figures.

Which One Do You Need?

For most people supplementing omega-3 for general health maintenance, a product providing meaningful amounts of both DHA and EPA covers all the relevant bases. The specific applications where you would actively choose one profile over another are:

Choose EPA-dominant if: your primary motivation is mood support, anxiety management, or the cardiovascular outcomes where EPA-dominant supplementation has shown the strongest effects. You want an EPA content of at least 60 percent of total omega-3, or a product providing at least 1,000 mg of EPA daily.

Choose DHA-dominant or DHA-prioritized if: your primary goals are brain structural health, cognitive performance, eye health, fetal and infant brain development, or the retinal health applications where DHA’s structural role is most relevant. A product like an algae oil supplement with a 2:1 DHA-to-EPA ratio serves these goals well.

For joint pain, athletic recovery, cardiovascular general health, and most other common applications, a balanced or moderately DHA-dominant product providing at least 500 mg of combined EPA and DHA per serving is appropriate. The ratio matters less than the dose, and the dose matters less than consistency of use over months.

The Bottom Line

DHA and EPA are distinct omega-3 fatty acids with different primary roles. DHA is primarily structural, concentrated in the brain, retina, and sperm, and drives the neurological, visual, and cognitive effects of omega-3 supplementation. EPA is primarily functional and anti-inflammatory, driving the mood, cardiovascular, joint, and inflammatory resolution effects that are most consistently associated with EPA content in clinical research. For most people and most supplementation goals, a product providing both at meaningful doses covers the relevant mechanisms. When a specific clinical application points clearly toward one fatty acid over the other, the supplement facts panel is where you find out whether your current supplement is actually aligned with your goal.

Sources

• Calder, P.C. (2012). Mechanisms of action of (n-3) fatty acids. Journal of Nutrition, 142(3), 592S-599S.
• Liao, Y., et al. (2019). Efficacy of omega-3 PUFAs in depression: a meta-analysis. Translational Psychiatry, 9(1), 190.
• SanGiovanni, J.P., and Chew, E.Y. (2005). The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in Retinal and Eye Research, 24(1), 87-138.

Frequently Asked Questions

Is DHA or EPA more important for brain health?

DHA is the primary structural fatty acid in brain tissue and is the more directly relevant of the two for structural brain health, cognitive function, and neurological development. EPA contributes to brain health through its anti-inflammatory effects on neuroinflammation, which is relevant to mood, cognitive performance under inflammatory conditions, and brain aging. For structural and developmental brain health, DHA is the priority. For mood-related brain health, EPA is more specifically implicated.

Should I take more EPA or DHA for depression?

The clinical research on omega-3 and depression consistently implicates EPA as the more relevant fatty acid. Meta-analyses have found that the antidepressant effect of omega-3 supplementation is driven by formulations where EPA comprises at least 60 percent of the total omega-3 content. For depression-specific supplementation, choosing a product with a higher EPA content or ratio is better supported by the evidence than a DHA-dominant product.

What does a 2:1 DHA to EPA ratio mean on a supplement label?

A 2:1 DHA-to-EPA ratio means the product provides twice as much DHA as EPA per serving. This ratio is common in algae oil supplements, reflecting the natural fatty acid profile of the microalgae species most commonly used for commercial DHA and EPA production. It is a DHA-dominant formulation well-suited to brain structural health, eye health, and general omega-3 maintenance, though it provides less EPA relative to DHA than some applications specifically call for.

Can I take separate DHA and EPA supplements?

Yes. Some people with specific clinical goals choose a combined supplement for general maintenance and add a high-EPA product for targeted mood or cardiovascular support. More commonly, choosing a supplement whose DHA-to-EPA ratio is aligned with your primary goals is sufficient. Very few people need to supplement the two fatty acids completely separately, and most quality combined products cover the relevant bases for the majority of supplementation goals.